Association of the CTG (-2578/-460/+405) haplotype within the vascular endothelial growth factor gene with early-onset psoriasis

Tissue Antigens

Volumn 72, Issue 5, 2008, Pages 458-463

  Wongpiyabovorn, J ^a   Yooyongsatit, S ^a   Ruchusatsawat, K ^b   Avihingsanon, Y ^a   Hirankarn, N ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Psoriasis; Single nucleotide polymorphism; Vascular endothelial growth factor gene

Indexed keywords

MYELOID ZINC FINGER PROTEIN 1; TRANSCRIPTION FACTOR GATA 2; UNCLASSIFIED DRUG; VASCULOTROPIN; ZINC FINGER PROTEIN;

5' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; BINDING SITE; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE COURSE; ETHNICITY; EXON; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSORIASIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PSORIASIS; THAILAND; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

THAIS;

EID: 54049084934     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2008.01134.x     Document Type: Article

References (40)

1. Greaves MW, Weinstein GD. Treatment of psoriasis. N Engl J Med 1995 : 332 : 581 8.
2. Nickoloff BJ, Nestle FO. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest 2004 : 113 : 1664 75.
3. Campalani E, Barker JNWN. The clinical genetics of psoriasis. Curr Genomics 2005 : 6 : 51 60.
4. Bowcock AM, Krueger JG. Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol 2005 : 5 : 699 711.
5. Creamer D, Sullivan D, Bicknell R, Barker J. Angiogenesis in psoriasis. Angiogenesis 2002 : 5 : 231 6.
6. Bos JD, De Rie MA. The pathogenesis of psoriasis: immunological facts and speculations. Immunol Today 1999 : 20 : 40 6.
7. Luba KM, Stulberg DL. Chronic plaque psoriasis. Am Fam Physician 2006 : 73 : 636 44.
8. Uyemura K, Yamamura M, Fivenson DF, Modlin RL, Nickoloff BJ. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 1993 : 101 : 701 5.
9. Ruchusatsawat K, Wongpiyabovorn J, Shuangshoti S, Hirankarn N, Mutirangura A. SHP-1 promoter 2 methylation in normal epithelial tissues and demethylation in psoriasis. J Mol Med 2006 : 84 : 175 82.
10. Trembath RC, Clough RL, Rosbotham JL et al. Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet 1997 : 6 : 813 20.
11. Burden AD, Javed S, Bailey M, Hodgins M, Connor M, Tillman D. Genetics of psoriasis: paternal inheritance and a locus on chromosome 6p. J Invest Dermatol 1998 : 110 : 958 60.
12. Schon MP, Boehncke WH. Psoriasis. N Engl J Med 2005 : 352 : 1899 912.
13. Bowcock AM, Cookson WO. The genetics of psoriasis, psoriatic arthritis and atopic dermatitis. Hum Mol Genet 2004 : 13 : R43 55.
14. Young HS, Summers AM, Bhushan M, Brenchley PE, Griffiths CE. Single-nucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset. J Invest Dermatol 2004 : 122 : 209 15.
15. Unemori EN, Ferrara N, Bauer EA, Amento EP. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol 1992 : 153 : 557 62.
16. Clauss M, Gerlach M, Gerlach H et al. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 1990 : 172 : 1535 45.
17. Schon MP. Animal models of psoriasis - what can we learn from them? J Invest Dermatol 1999 : 112 : 405 10.
18. Xia YP, Li B, Hylton D, Detmar M, Yancopoulos GD, Rudge JS. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 2003 : 102 : 161 8.
19. Detmar M, Brown LF, Claffey KP et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 1994 : 180 : 1141 6.
20. Bhushan M, McLaughlin B, Weiss JB, Griffiths CE. Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis. Br J Dermatol 1999 : 141 : 1054 60.
21. Diaz BV, Lenoir MC, Ladoux A, Frelin C, Demarchez M, Michel S. Regulation of vascular endothelial growth factor expression in human keratinocytes by retinoids. J Biol Chem 2000 : 275 : 642 50.
22. Hernandez GL, Volpert OV, Iniguez MA et al. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2. J Exp Med 2001 : 193 : 607 20.
23. Mastroianni A, Minutilli E, Mussi A et al. Cytokine profiles during infliximab monotherapy in psoriatic arthritis. Br J Dermatol 2005 : 153 : 531 6.
24. Young HS, Summers AM, Read IR et al. Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis. J Invest Dermatol 2006 : 126 : 453 9.
25. Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000 : 12 : 1232 5.
26. Barile S, Medda E, Nistico L et al. Vascular endothelial growth factor gene polymorphisms increase the risk to develop psoriasis. Exp Dermatol 2006 : 15 : 368 76.
27. Wang Z, Liang W, Zhang B, Lv M, Wang J, Zhang L. Single nucleotide polymorphisms of VEGF gene and psoriasis risk. J Dermatol Sci 2008 : 49 : 263 5.
28. Shahbazi M, Fryer AA, Pravica V et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 2002 : 13 : 260 4.
29. Papazoglou D, Galazios G, Koukourakis MI et al. Vascular endothelial growth factor gene polymorphisms and pre-eclampsia. Mol Hum Reprod 2004 : 10 : 321 4.
30. Szeto CC, Chow KM, Poon P, Szeto CY, Wong TY, Li PK. Genetic polymorphism of VEGF: impact on longitudinal change of peritoneal transport and survival of peritoneal dialysis patients. Kidney Int 2004 : 65 : 1947 55.
31. Breunis WB, Biezeveld MH, Geissler J et al. Vascular endothelial growth factor gene haplotypes in Kawasaki disease. Arthritis Rheum 2006 : 54 : 1588 94.
32. Brogan IJ, Khan N, Isaac K, Hutchinson JA, Pravica V, Hutchinson IV. Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene. Hum Immunol 1999 : 60 : 1245 9.
33. Koukourakis MI, Papazoglou D, Giatromanolaki A, Bougioukas G, Maltezos E, Sivridis E. VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer 2004 : 46 : 293 8.
34. Lip GY, Chung I. Vascular endothelial growth factor and angiogenesis in heart failure. J Card Fail 2005 : 11 : 285 7.
35. Lin CC, Wu HC, Tsai FJ, Chen HY, Chen WC. Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for prostate cancer. Urology 2003 : 62 : 374 7.
36. Bhanoori M, Arvind Babu K, Pavankumar Reddy NG et al. The vascular endothelial growth factor (VEGF) +405G>C 5'-untranslated region polymorphism and increased risk of endometriosis in South Indian women: a case control study. Hum Reprod 2005 : 20 : 1844 9.
37. Dean AG, Dean JA, Burton AH, Dicker RC. Epi Info: a general-purpose microcomputer program for public health information systems. Am J Prev Med 1991 : 7 : 178 82.
38. Stephens M, Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003 : 73 : 1162 9.
39. Hill WG. Estimation of linkage disequilibrium in randomly mating populations. Heredity 1974 : 33 : 229 39.
40. Kim DH, Lee NY, Lee MH, Sohn SK, Do YR, Park JY. Vascular endothelial growth factor (VEGF) gene (VEGFA) polymorphism can predict the prognosis in acute myeloid leukaemia patients. Br J Haematol 2008 : 140 : 71 9.